Memahami Penyakit Paru Interstisial: Pengenalan Dini pada Layanan Kesehatan Primer
DOI:
https://doi.org/10.55175/cdk.v51i4.1092Kata Kunci:
Gangguan paru, penyakit paru interstisial, profesional kesehatan primerAbstrak
Penyakit paru interstisial atau interstitial lung disease (ILD) mencakup sekelompok gangguan paru heterogen dengan etiologi dan presentasi klinis yang bervariasi. Diagnosis dini ILD sangat penting untuk intervensi tepat waktu dan perbaikan pasien. Minireview ini menyoroti pentingnya diagnosis dini ILD di pusat kesehatan primer, dengan fokus pada manfaat dan tantangan terkait deteksi dini, serta peran profesional kesehatan primer dalam mencapai diagnosis tepat waktu. Profesional kesehatan primer memainkan peran penting dalam mengenali tanda dan gejala awal ILD, melakukan evaluasi awal, dan membimbing pasien melalui proses diagnostik. Upaya kolaboratif antara profesional kesehatan primer, pulmonolog, dan radiolog sangat penting untuk mengatasi tantangan tersebut dan memastikan diagnosis tepat waktu.
Unduhan
Referensi
Aronson KI, Swigris JJ, Bajwah S, Bianchi P, Corte TJ, Danoff SK, et al. Patient-centered outcomes research in interstitial lung disease: An official american thoracic society research statement. Am J Respir Crit Care Med. 2021;204(2):e3-23.
Kaul B, Cottin V, Collard HR, Valenzuela C. Variability in global prevalence of interstitial lung disease. Front Med. 2021;8:751181.
Wallis A, Spinks K. The diagnosis and management of interstitial lung diseases. BMJ. 2015;350(May):1–12.
Global Burden of Disease Collaborative Network. Global burden of disease study 2019 (GBD 2019) reference life table. Institute for Health Metrics and Evaluation [Internet]. 2019 [cited 2023 September 22]. Available from: https://ghdx.healthdata.org/record/ihme-data/global-burden-disease-study-2019-gbd-2019-reference-life-table.
Shah Gupta R, Koteci A, Morgan A, George PM, Quint JK. Incidence and prevalence of interstitial lung diseases worldwide: A systematic literature review. BMJ Open Respir Res. 2023;10(1):e001291.
Kalchiem-Dekel O, Galvin JR, Burke AP, Atamas SP, Todd NW. Interstitial lung disease and pulmonary fibrosis: A practical approach for general medicine physicians with focus on the medical history. J Clin Med. 2018;7(12):476.
Glasser SW, Hardie WD, Hagood JS. Pathogenesis of interstitial lung disease in children and adults. Pediatr Allergy, Immunol Pulmonol. 2010;23(1):9-14.
Alsomali H, Palmer E, Aujayeb A, Funston W. Early diagnosis and treatment of idiopathic pulmonary fibrosis: A narrative review. Pulm Ther. 2023;9(2):177–93.
Berger K, Kaner RJ. Diagnosis and pharmacologic management of fibrotic interstitial lung disease. Life 2023;13(3):599.
Mikolasch TA, Garthwaite HS, Porter JC. Update in diagnosis and management of interstitial lung Disease. Clin Med J R Coll Physicians London. 2017;17(2):146–53.
Griese M. Etiologic classification of diffuse parenchymal (interstitial) lung diseases. J Clin Med. 2022;11(6):1747.
Adegunsoye A, Ryerson CJ. Diagnostic classification of interstitial lung disease in clinical practice. Clin Chest Med. 2021;42(2):251-61. DOI: 10.1016/j.ccm.2021.03.002.
Sinha A, Patel AS, Siegert RJ, Bajwah S, Maher TM, Renzoni EA, et al. The king’s brief interstitial lung disease (KBILD) questionnaire: An updated minimal clinically important difference. BMJ Open Respir Res. 2019;6(1):e000363.
Rousan LA, Elobeid E, Karrar M, Khader Y. Chest x-ray findings and temporal lung changes in patients with COVID-19 pneumonia. BMC Pulm Med. 2020;20(1):245. DOI: 10.1186/s12890-020-01286-5.
Hansell DM, Bankier AA, MacMahon H, McLoud TC, Müller NL, Remy J. Fleischner society: Glossary of terms for thoracic imaging. Radiology 2008;246(3):697–722.
Vizioli L, Ciccarese F, Forti P, Chiesa AM, Giovagnoli M, Mughetti M, et al. Integrated use of lung ultrasound and chest X-ray in the detection of interstitial lung disease. Respiration 2017;93(1):15-22. DOI: 10.1159/000452225.
Raghu G, Collard HR, Egan JJ, Martinez FJ, Behr J, Brown KK, et al. An official ATS/ERS/JRS/ALAT statement: Idiopathic pulmonary fibrosis: Evidencebased guidelines for diagnosis and management. Am J Respir Crit Care Med. 2011;183(6): 788–824. DOI: 10.1164/rccm.2009-040GL
Maher TM, Wuyts W. Management of fibrosing interstitial lung diseases. Adv Ther. 2019;36(7):1518-31. DOI: 10.1007/s12325-019-00992-9.
Lindell KO. Nonpharmacological therapies for interstitial lung disease. Curr Pulmonol Reports. 2018;7(4):126–32. DOI: 10.1007/s13665-018-0211-6.
Leuschner G, Behr J. Acute exacerbation in interstitial lung disease. Front Med. 2017;4:176.
Unduhan
Diterbitkan
Cara Mengutip
Terbitan
Bagian
Lisensi
Hak Cipta (c) 2024 Altama Latona Sidarta, Menaldi Rasmin
Artikel ini berlisensi Creative Commons Attribution-NonCommercial 4.0 International License.
